Citation Impact
Citing Papers
In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles
2002 StandoutScience
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals
2008 StandoutNobel
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
2020 StandoutScience
Inference and control of the nosocomial transmission of methicillin-resistant Staphylococcus aureus
2018
Can We Treat Our Way Out of HIV?
2010
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions
2021 StandoutNobel
The Impact of the New WHO Antiretroviral Treatment Guidelines on HIV Epidemic Dynamics and Cost in South Africa
2011
The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa
2006
The Case for Earlier Treatment of HIV Infection
2004
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals
2003
Social and environmental risk factors in the emergence of infectious diseases
2004
Inflammation and metabolic disorders
2006 StandoutNature
Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
2010
Modelling the Impact of Antiretroviral Use in Resource-Poor Settings
2006
Expanded Access to Highly Active Antiretroviral Therapy: A Potentially Powerful Strategy to Curb the Growth of the HIV Epidemic
2008
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Global trends in emerging infectious diseases
2008 StandoutNature
Population Distribution, Settlement Patterns and Accessibility across Africa in 2010
2012
Universal Voluntary Testing and Treatment for Prevention of HIV Transmission
2009
Expanding ART for Treatment and Prevention of HIV in South Africa: Estimated Cost and Cost-Effectiveness 2011-2050
2012
Effects of Temperature on Physiology and Reproductive Success of a Montane Leaf Beetle: Implications for Persistence of Native Populations Enduring Climate Change
2008
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
2012
HIV-1 Transmission, by Stage of Infection
2008
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
HIV-1 treatment as prevention: the good, the bad, and the challenges
2011
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
2010
Emergent heterogeneity in declining tuberculosis epidemics
2007
Modelling disease outbreaks in realistic urban social networks
2004 StandoutNature
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study
2011
Dynamically Modeling SARS and Other Newly Emerging Respiratory Illnesses
2005
Missed Visits and Mortality among Patients Establishing Initial Outpatient HIV Treatment
2008
The basic reproduction number (R0) of measles: a systematic review
2017
The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda
2004
Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis
2009
Risk compensation: the Achilles' heel of innovations in HIV prevention?
2006
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
2020 Standout
Prospects for worldwide tuberculosis control under the WHO DOTS strategy
1998
Blue Luminescence from (CdS)ZnS Core–Shell Nanocrystals
2004 StandoutNobel
Prevalence, risk factors, and molecular epidemiology of methicillin-resistant Staphylococcus aureus among newly arrested men in Baltimore, Maryland
2008
FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model
2010
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
2011
Climate change and evolutionary adaptation
2011 StandoutNature
The challenge of emerging and re-emerging infectious diseases
2004 StandoutNature
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
Ecological responses to recent climate change
2002 StandoutNature
Quantifying TB transmission: a systematic review of reproduction number and serial interval estimates for tuberculosis
2018
Strategies for mitigating an influenza pandemic
2006 StandoutNature
Long‐Term Trends of HIV Type 1 Drug Resistance Prevalence among Antiretroviral Treatment–Experienced Patients in Switzerland
2009
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
2006
The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection
1997
The global situation of MDR-TB
2003
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Global Implications of the Emergence of Community‐Associated Methicillin‐ResistantStaphylococcus aureusin Indigenous Populations
2008
The protein network as a tool for finding novel drug targets
2007
Decline in HIV infectivity following the introduction of highly active antiretroviral therapy
2004
Individual-based Perspectives on R0
2000
INTERACTIONS BETWEEN MACROPARASITES AND MICROPARASITES DRIVE INFECTION PATTERNS IN FREE-RANGING AFRICAN BUFFALO
2008
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034
2006
Renal clearance of quantum dots
2007 StandoutNobel
Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission
2002 Standout
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world
2011
Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection
1995
Emerging infectious disease: what are the relative roles of ecology and evolution?
1995
SARS-CoV-2 in wastewater: State of the knowledge and research needs
2020 Standout
Concentrations and size distributions of airborne influenza A viruses measured indoors at a health centre, a day-care centre and on aeroplanes
2011
Declining Prevalence of HIV-Infected Individuals at Risk of Transmitting Drug-Resistant HIV in Denmark during 1997–2004
2006
Modeling Infection Transmission
2004
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
2008
Infectious Diseases and Human Population History
1996
Long-Term Follow-Up of Methicillin-Resistant Staphylococcus aureus Molecular Epidemiology after Emergence of Clone USA300 in San Francisco Jail Populations
2008
1.3 μm to 1.55 μm Tunable Electroluminescence from PbSe Quantum Dots Embedded within an Organic Device
2003 StandoutNobel
Quantifying the Impact of Human Mobility on Malaria
2012 StandoutScience
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
2002 Science
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
2005 StandoutScience
The Fluid Dynamics of Disease Transmission
2020
Conjugation of Luminescent Quantum Dots with Antibodies Using an Engineered Adaptor Protein To Provide New Reagents for Fluoroimmunoassays
2002
Quantum Dot-Based Multiplexed Fluorescence Resonance Energy Transfer
2005 StandoutNobel
Population Biology, Evolution, and Infectious Disease: Convergence and Synthesis
1999 Science
Complete Protection from Repeated Vaginal Simian-Human Immunodeficiency Virus Exposures in Macaques by a Topical Gel Containing Tenofovir Alone or with Emtricitabine
2009
Self-Assembly of CdSe−ZnS Quantum Dot Bioconjugates Using an Engineered Recombinant Protein
2000 StandoutNobel
Exploring links between physiology and ecology at macro‐scales: the role of respiratory metabolism in insects
1999
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Oligomeric Ligands for Luminescent and Stable Nanocrystal Quantum Dots
2003 StandoutNobel
Phosphine Oxide Polymer for Water-Soluble Nanoparticles
2005 StandoutNobel
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations
2006
Economic benefit of Tuberculosis control
2007
Nanoparticles with Raman Spectroscopic Fingerprints for DNA and RNA Detection
2002 StandoutScience
Frequency–dependent incidence in models of sexually transmitted diseases: portrayal of pair–based transmission and effects of illness on contact behaviour
2004
Multiplexed Toxin Analysis Using Four Colors of Quantum Dot Fluororeagents
2003
Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
2009
A Continuous‐Flow Microcapillary Reactor for the Preparation of a Size Series of CdSe Nanocrystals
2003 StandoutNobel
The Parable of Google Flu: Traps in Big Data Analysis
2014 StandoutScience
Size Series of Small Indium Arsenide−Zinc Selenide Core−Shell Nanocrystals and Their Application to In Vivo Imaging
2006 StandoutNobel
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo
2003 StandoutScience
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination
1997 Standout
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
Entering the Century of the Environment: A New Social Contract for Science
1998 StandoutScience
Type-II Quantum Dots: CdTe/CdSe(Core/Shell) and CdSe/ZnTe(Core/Shell) Heterostructures
2003 StandoutNobel
Airborne transmission of respiratory viruses
2021 StandoutScience
Competing Risks and Multistate Models with R
2011
Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis
2018 StandoutNobel
Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?
2010
Avidin: A Natural Bridge for Quantum Dot-Antibody Conjugates
2002
Fluorescence Resonance Energy Transfer Between Quantum Dot Donors and Dye-Labeled Protein Acceptors
2003 StandoutNobel
Works of Sally Blower being referenced
The continuing HIV epidemic among men who have sex with men
2001
How far will we need to go to reach HIV-infected people in rural South Africa?
2007
Drugs, sex and HIV : a mathematical model for New York City
1991
The Emergence of HIV Transmitted Resistance in Botswana: “When Will the WHO Detection Threshold Be Exceeded?”
2007
Calculating the potential for within-flight transmission of influenza A (H1N1)
2009
HIV transmission in sexual networks: an empirical analysis
1995
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics?
2002
Modelling an outbreak of an emerging pathogen
2007
Early Therapy for Latent Tuberculosis Infection
2001
Modelling HIV vaccination
1995
Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco
1994 Science
Imperfect vaccines and herd immunity to HIV
1993
Designing Equitable Antiretroviral Allocation Strategies in Resource-Constrained Countries
2005
Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework
1998
Leprosy and tuberculosis: the epidemiological consequences of cross-immunity.
1997
Theory versus Data: How to Calculate R0?
2007
What can modeling tell us about the threat of antiviral drug resistance?
2002
Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance
2004
The intrinsic transmission dynamics of tuberculosis epidemics
1995
Predicting and preventing the emergence of antiviral drug resistance in HSV-2
1998
Predicting the Impact of Antiretrovirals in Resource-Poor Settings: Preventing HIV Infections whilst Controlling Drug Resistance
2003
Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1)
2009
Evaluating the potential impact of vaginal microbicides to reduce the risk of acquiring HIV in female sex workers
2005
Predicting the transmission of drug-resistant HIV: comparing theory with data
2003
Uncertainty and Sensitivity Analysis of the Basic Reproductive Rate: Tuberculosis as an Example
1997
Infectious syphilis in high-income settings in the 21st century
2008
Predicting the unpredictable: Transmission of drug-resistant HIV
2001
Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco
2010 Science
Narrative Review: Antiretroviral Therapy to Prevent the Sexual Transmission of HIV-1
2007
Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.
2003
ADAPTATION AT SPECIFIC LOCI. IV. DIFFERENTIAL MATING SUCCESS AMONG GLYCOLYTIC ALLOZYME GENOTYPES OF COLIAS BUTTERFLIES
1985
An attempt at a new analysis of the mortality caused by smallpox and of the advantages of inoculation to prevent it
2004
The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models
2004
Control Strategies for Tuberculosis Epidemics: New Models for Old Problems
1996 Science
Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: An HIV Model, as an Example
1994